Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
Mansur A GhaniArash FereydooniEvan ChenBrian LetzenFabian Laage-GauppNariman NezamiYanhong DengGeliang GanVinayak ThakurMingDe LinXenophon PapademetrisRuediger E SchernthanerSteffen HuberJulius ChapiroKelvin HongChristos GeorgiadesPublished in: European radiology (2021)
• Tumor enhancement of colorectal cancer liver metastases on MRI prior to treatment with intra-arterial therapies is strongly associated with patient survival. • Three-dimensional, enhancement-based imaging biomarkers such as enhancing tumor volume and enhancing tumor burden may serve as the basis of a novel prognostic staging system for patients with liver-dominant colorectal cancer metastases.